2027 Food and Drug Administration Healthcare Physicians 
European Pharmaceutical Review
JANUARY 19, 2023
The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.
European Pharmaceutical Review
MARCH 4, 2024
1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5
Expert insights. Personalized for you.
80 
Let's personalize your content